Skip to main content
Caplight Logo









Invenra

Invenra

Private
Madison, WisconsinHealthcare & Life Scienceshttps://invenra.com

Last Round

Debt

Apr 10, 2020

Total Funding Raised

$19.84M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Invenra operates in Healthcare & Life Sciences and is based in Madison, Wisconsin. Its latest recorded funding round was a Debt round in April 2020.

Invenra is a biotechnology company that specializes in the discovery and development of next-generation multispecific antibody therapeutics for oncology and other disease applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Usage-Based SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Invenra Comparables

Compare Invenra with similar companies based on industry and business-model similarity.

Invenra comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tentarix Biotherapeutics
86%
Adimab
81%
Radiant Biotherapeutics
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Invenra Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtApr 10, 2020
Series BOct 16, 2018
Series AOct 5, 2017
Series A ExtensionJul 20, 2016
Series A ExtensionAug 13, 2015
VC Round
Jan 28, 2015
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Tim Daley

Chief Financial Officer

Executive Team

For institutional investors. Book with your work email.

Invenra Investors

Notable investors and investment history

Invenra investors
InvestorRounds
Rose Ventures Inc.Series A
State of Wisconsin Investment BoardSeries B
Venture Investors LLCSeries B
State of Wisconsin Investment Board (SWIB)Series B
Venture Management, LLCSeries A Extension
Wisconsin Investment PartnersSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Monthly visitors increased 39% MoM, reaching 4.1K.

  • Jun 18, 2026

    Monthly visitors increased 125% MoM, reaching 3K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • attends_eventOct 12, 2026

    Invenra attends the World ADC Conference in California on Oct 12th '26 and debuts its "52 Views of Cancer" playing card deck.

  • launchesOct 12, 2026

    Invenra launches "52 Views of Cancer" Art deck, a playing-card deck featuring original artwork by people affected by cancer, at the World ADC Conference in California on Oct 12th '26.

  • is_developingOct 12, 2026

    Invenra is developing ADCs for cancers including ovarian, breast, lung, colon, neuroblastoma, osteosarcoma, rhabdomyosarcoma, Ewing's sarcoma, diffuse midline glioma, and glioblastoma.

Book a demo to see all news

For institutional investors. Book with your work email.

Invenra Filings

Explore SEC and related filing metadata, where available.

Invenra filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Invenra's valuation, stock price, and market status.

Is Invenra a public or private company?

Invenra is a private company.

What is the current stock price of Invenra?

Invenra is a private company, so its shares have no public market price. Caplight tracks Invenra's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Invenra worth (valuation)?

Valuation information for Invenra is not publicly available.

Can I buy Invenra stock?

Invenra shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Invenra's last funding round?

Invenra's most recent funding round was Debt on April 10, 2020.

Who are the main investors in Invenra?

Key investors in Invenra include Venture Investors LLC, Wisconsin Investment Partners.

Will Invenra IPO soon?

No public IPO plans have been announced for Invenra.

How can I track Invenra secondary market activity?

Caplight tracks bids, offers, and trades in Invenra's shares on secondary markets.

Firmographic Details

HeadquartersMadison, Wisconsin
Employee Range53
Year Founded2011
Last FundingApr 10, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?